Related Experiment Video
Updated: Jun 4, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Role of p21 in SP600125-induced cell cycle arrest, endoreduplication, and apoptosis
Dong-Oh Moon1, Yung Hyun Choi, Gi-Young Kim
1Laboratory of Immunobiology, Department of Marine Life Sciences, Jeju National University, Jeju 690-756, Republic of Korea.
Abstract:
The anti-cancer effect of the c-Jun N-terminal kinase (JNK) inhibitor SP600125 has been well evaluated in human cancer cells. However the role of p21 in SP600125-mediated G(2)/M distribution is not fully understood. Our results showed that the transcriptional activation of p21 by SP600125 is mediated through the proximal regions of multiple Sp1 sites in the p21 promoter following ERK-dependent phosphorylation of Sp1. In this process, p21 induces endoreduplication through the inhibition of cyclin E/Cdk2 activity at 24 h but does not directly regulate cyclin B1/Cdc2 activity. Furthermore, SP600125 induces the phosphorylation of p21 at Thr 145 through the PI3K/Akt pathway. Akt-mediated phosphorylation of p21 and protection of apoptosis are completely abolished by inhibitors of PI3K and Akt. In summary using time points, we identified the dual functions of p21 as an inhibitor of cell-cycle progression at 24 h and as an anti-apoptotic factor at 48 h.
Insights
The JNK inhibitor SP600125 activates p21, impacting cell cycle progression and apoptosis. This study reveals p21
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The anti-cancer effects of c-Jun N-terminal kinase (JNK) inhibitor SP600125 are recognized in human cancer cells.
- The precise role of p21 in SP600125-induced G(2)/M phase distribution remains unclear.
Purpose of the Study:
- To elucidate the role of p21 in the G(2)/M cell cycle distribution induced by SP600125.
- To investigate the mechanisms underlying p21 transcriptional activation and its functional consequences.
Main Methods:
- Investigated SP600125's effects on p21 promoter activity and Sp1 phosphorylation.
- Utilized inhibitors of ERK, PI3K, and Akt pathways to dissect signaling cascades.
- Assessed cell cycle distribution, endoreduplication, and apoptosis at specific time points.
Main Results:
- SP600125 induces transcriptional activation of p21 via ERK-dependent Sp1 phosphorylation.
- p21 inhibits cyclin E/Cdk2 activity, leading to endoreduplication at 24 hours.
- SP600125 triggers PI3K/Akt-mediated p21 phosphorylation at Thr 145, conferring anti-apoptotic protection at 48 hours.
Conclusions:
- p21 exhibits dual functions: inhibiting cell cycle progression at 24 hours and acting as an anti-apoptotic factor at 48 hours.
- The PI3K/Akt pathway is crucial for SP600125-induced p21 phosphorylation and subsequent apoptosis protection.
Related Concept Videos
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

